CVRdatabase
Menu

Vipergen ApS

Private limited companyCVR 28851758København VActive

Vipergen ApS is a private limited company, based in København V, active in research and experimental development on natural sciences and engineering, founded in 2005. The company made a loss in both 2024 and 2025, most recently DKK 1.9m. With 16 employees, the company is about 3 times larger than the industry median. Equity fell to DKK 4.7m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 10.8m−11.9% vs. 2024
Net profit−DKK 1.9m−504.2% vs. 2024
EquityDKK 4.7m−29% vs. 2024
Employees16latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 12% (2024 → 2025), to DKK 10.8m.
  • The loss grew: from DKK 318k to DKK 1.9m (2024 → 2025).
  • Equity fell 29% (2024 → 2025), to DKK 4.7m.

Employees

  • 1 more employees than a year earlier: 16 (08/2026) against 15 (08/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4mDKK 6mDKK 8m202020212022202320242025
EquityNet profit
Financial figures for Vipergen ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit3,12819,95912,65919,05312,30510,839−11.9%
Operating profit (EBIT)−6,1148,8824426,242−267−1,931−623%
Profit before tax−6,3558,4392196,031−643−2,465−283.4%
Net profit−6,3488,4661,0544,904−318−1,920−504.2%
Total assets5,75513,7148,60717,54031,65341,061+29.7%
Equity−7,4769902,0446,9486,6304,710−29%
Liabilities13,21312,7246,5639,22921,92831,520+43.7%
Cash and cash equivalents1504,4633,5522,0072,1961,691−23%
Average number of employees1214171715150%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12mDKK 14mDKK 16mDKK 18mDKK 20m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Vipergen ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202427/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202321/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202214/04/2023The companyPDFXBRL
202101/01/2021 – 31/12/202107/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202028/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101214161809/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 10.8mNo. 75 of 421
Better than 82% of the companies in the industry
EquityDKK 4.7mNo. 182 of 431
Better than 58% of the companies in the industry
Number of employees16No. 111 of 431
Better than 74% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 4,196of 69,742
Better than 94%
No. 14,704of 69,964
Better than 79%
Same industry and fewer than 20 employees329 companies in the comparison
No. 19of 323
Better than 94%
No. 98of 329
Better than 70%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 5,602of 24,791
Better than 77%
No. 10,015of 24,909
Better than 60%
All companies of type ApS66,508 companies in the comparison
No. 5,499of 66,379
Better than 92%
No. 11,731of 66,505
Better than 82%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Vipergen ApSDKK 10.8m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Vipergen ApS−DKK 1.9m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Vipergen ApSDKK 4.7m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Vipergen ApS16
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Vipergen ApS

Management

3 active registrations

Executive management

Executive management at Vipergen ApS
NameRoleAppointed
Nils Jakob Vest HansenDirector22/06/2005

Board of directors

Board of directors at Vipergen ApS
NameRoleAppointed
Nils Jakob Vest HansenBoard member06/07/2005
Gunnar KjemsChair of the board11/06/2014
Auditor
Buus Jensen I/S Statsautoriserede Revisorer
Founders
Nils Jakob Vest Hansen
Former management (2)
Former management at Vipergen ApS
NameRoleAppointedResigned
Gunnar KjemsBoard member06/07/200510/06/2014
Eigil Bjerl NielsenChair of the board06/07/200511/06/2014

Signing rule: Selskabet repræsenteres i alle forhold af direktøren, som kan tegne Selskabet. Selskabet kan endvidere tegnes af bestyrelsesformanden eller af to af bestyrelsens medlemmer eller den samlede bestyrelse i forening

Address and production units

1 active production units

Gammel Kongevej 23A
1610 København V

København Municipality · Postcode 1610

Production units
Production unitAddressEmployeesP number
VIPERGEN ApSGammel Kongevej 23A, 1, 1610 København V161011493412

Purpose

Selskabets formål er direkte eller indirekte at drive virksomhed med forskning og udvikling, og hvad der relaterer sig hertil. Selskabet indgår som komplementar VIPERGEN Pharmaceuticals K/S.

The purpose is quoted from the register in Danish.

Changes year by year

23 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20171 changecapital 1
  • Share capital changed from 136,450 DKK to 218,575 DKK
20145 changesownership 2 · management 3
  • Gunnar Kjems registered as owner (33.33%)
  • Nils Jakob Vest Hansen registered as owner (50%)
  • Gunnar Kjems appointed chair of the board
  • Eigil Bjerl Nielsen stepped down as chair of the board
  • Gunnar Kjems stepped down as board member
20091 changeaddress 1
  • Moved to Gammel Kongevej 23A, 1, 1610 København V
20081 changeindustry 1
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20061 changecapital 1
  • Share capital changed from 125,000 DKK to 136,450 DKK
20057 changesname 1 · address 1 · management 4 · founded 1
  • Name changed from VIPERGEN PHARMACEUTICALS ApS to VIPERGEN ApS
  • Moved to Fruebjergvej 3, 2100 København Ø
  • Gunnar Kjems appointed board member
  • Eigil Bjerl Nielsen appointed chair of the board
  • Nils Jakob Vest Hansen appointed board member
  • Registered as VIPERGEN PHARMACEUTICALS ApS
  • Nils Jakob Vest Hansen appointed director

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction